These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 11378495

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors.
    Etzel A, Shibata GY, Rozman M, Jorge ML, Damas CD, Segurado AA.
    J Acquir Immune Defic Syndr; 2001 Feb 01; 26(2):185-90. PubMed ID: 11242188
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversity.
    Teixeira SL, Bastos FI, Telles PR, Hacker MA, Brigido LF, de F Oliveira CA, Bongertz V, Morgado MG.
    J Clin Virol; 2004 Nov 01; 31(3):221-6. PubMed ID: 15465416
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
    Telzak EE, Hershow R, Kalish LA, Hardy WD, Zuckerman E, Levine A, Delapenha R, DeHovitz J, Greenblatt RM, Anastos K.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 15; 19(5):513-8. PubMed ID: 9859966
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand.
    Saguanwongse S, Muangpom A, Ruchusatsawat N, Wongcheree S, Warachit P, Miyamura K, Yamazaki S, Honda M.
    Microbiol Immunol; 1996 Dec 15; 40(9):639-44. PubMed ID: 8908608
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular epidemiology of HIV-1 in Brazil: high prevalence of HIV-1 subtype B and identification of an HIV-1 subtype D infection in the city of Rio de Janeiro, Brazil. Evandro Chagas Hospital AIDS Clinical Research Group.
    Morgado MG, Guimarães ML, Gripp CB, Costa CI, Neves I, Veloso VG, Linhares-Carvalho MI, Castello-Branco LR, Bastos FI, Kuiken C, Castilho EA, Galvão-Castro B, Bongertz V.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug 15; 18(5):488-94. PubMed ID: 9715846
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Seroprevalence and molecular epidemiology of HTLV-1 isolates from HIV-1 co-infected women in Feira de Santana, Bahia, Brazil.
    de Almeida Rego FF, Mota-Miranda A, de Souza Santos E, Galvão-Castro B, Alcantara LC.
    AIDS Res Hum Retroviruses; 2010 Dec 15; 26(12):1333-9. PubMed ID: 20929351
    [Abstract] [Full Text] [Related]

  • 19. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
    van den Hoek JA, Al EJ, Huisman JG, Goudsmit J, Coutinho RA.
    J Med Virol; 1991 Jun 15; 34(2):100-3. PubMed ID: 1890409
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994.
    Broutet N, de Queiroz Sousa A, Basilio FP, Sá HL, Simon F, Dabis F.
    Int J STD AIDS; 1996 Jun 15; 7(5):365-9. PubMed ID: 8894828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.